Latest Administration News

Actinogen Medical’s pivotal XanaMIA Alzheimer’s trial stays on track for November topline results, buoyed by strong open-label extension enrolment and aligned EMA-FDA regulatory advice. A new antidepressant study publication and fresh patents add momentum, supported by a $16.7 million cash runway to mid-2027.

Alterity Therapeutics has cleared a major regulatory hurdle with the FDA endorsing a single pivotal Phase 3 trial for its ATH434 drug in Multiple System Atrophy, setting the stage for trial initiation by the end of 2026.

Lac Gold Limited's latest drilling at the Rouyn Gold Project reveals extensive high-grade gold mineralisation, while the acquisition of the historic Golden Patricia Mine adds a significant growth platform. The company ends the quarter with $13.3 million in cash and a clear focus on resource expansion.

Anson Resources has dramatically expanded its Green River Lithium Project resource and confirmed robust project economics, while sealing a key agreement with POSCO for a demonstration plant funded by the Korean industrial giant.

Ragusa Minerals has secured a controlling stake in Pegasus Tel Inc., gaining the Purple Pansy manganese-gold project in Arizona. Recent surveys and assays highlight promising high-grade manganese and gold mineralisation, positioning the company in a strategically important US critical minerals sector.

Hot Chili Limited is accelerating development at its La Verde copper-gold deposit in Chile, reporting strong drilling results and securing an additional US$15 million via an amended royalty agreement with OR Royalties. The company is progressing environmental assessments and pre-feasibility studies for the broader Costa Fuego project while maintaining a robust cash position.

Red Sky Energy has kicked off site works for a Santos-operated drilling campaign at the Innamincka Dome, secured $5.1 million in capital raising, and reported $1.045 million in production receipts for the June quarter.

Viking Mines has secured full permitting and contractor engagement for its maiden 63-hole drilling campaign at the Linka Tungsten Project in Nevada, alongside metallurgical testwork exceeding recovery targets and a strategic divestment of its First Hit Gold Project.

OncoSil Medical reported a 53% increase in unit sales and advanced key regulatory approvals, including FDA final review and TGA listing, positioning it for growth in pancreatic cancer treatment.

Nordic Resources (ASX:NNL) has reported final assays from its 1H 2026 drilling in Finland, revealing record gold grades at Kopsa and significant resource extensions across its key gold projects. Metallurgical testing is underway, with updated resource estimates expected later this year.

Avecho Biotechnology has secured a unanimous recommendation to continue its Phase III insomnia trial without increasing sample size, alongside raising $1.9 million through option exercises and bolstering its cash position to $6.6 million.

Fulcrum Lithium’s Phase 3 drilling at Alkali Flats reveals thick, continuous lithium zones with high-grade intervals, while Dry Canyon exploration advances with large-scale targets and claim expansions.